Nanosphere Health Sciences Stock Performance
| NSHSF Stock | USD 0.01 0 10.00% |
Nanosphere Health holds a performance score of 5 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -3.48, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Nanosphere Health are expected to decrease by larger amounts. On the other hand, during market turmoil, Nanosphere Health is expected to outperform it. Use Nanosphere Health information ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to analyze future returns on Nanosphere Health.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Nanosphere Health Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Nanosphere Health reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 12.9 K | |
| Free Cash Flow | -64.7 K |
Nanosphere |
Nanosphere Health Relative Risk vs. Return Landscape
If you would invest 2.00 in Nanosphere Health Sciences on September 30, 2025 and sell it today you would lose (0.68) from holding Nanosphere Health Sciences or give up 34.0% of portfolio value over 90 days. Nanosphere Health Sciences is currently producing 1.8951% returns and takes up 26.0149% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Nanosphere, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Nanosphere Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nanosphere Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nanosphere Health Sciences, and traders can use it to determine the average amount a Nanosphere Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0728
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | NSHSF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Nanosphere Health is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nanosphere Health by adding it to a well-diversified portfolio.
Nanosphere Health Fundamentals Growth
Nanosphere Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nanosphere Health, and Nanosphere Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nanosphere Pink Sheet performance.
| Return On Asset | -1.37 | |||
| Current Valuation | 298.63 K | |||
| Shares Outstanding | 10.28 M | |||
| Price To Book | 3.84 X | |||
| Price To Sales | 4.93 X | |||
| EBITDA | (386 K) | |||
| Cash And Equivalents | 88.45 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 44.7 K | |||
| Debt To Equity | 0.41 % | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (64.68 K) | |||
| Earnings Per Share | 0.04 X | |||
| Total Asset | 132.51 K | |||
About Nanosphere Health Performance
By analyzing Nanosphere Health's fundamental ratios, stakeholders can gain valuable insights into Nanosphere Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nanosphere Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nanosphere Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. The company was incorporated in 2005 and is headquartered in Vancouver, Canada. Nanosphere Health is traded on OTC Exchange in the United States.Things to note about Nanosphere Health performance evaluation
Checking the ongoing alerts about Nanosphere Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nanosphere Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nanosphere Health is way too risky over 90 days horizon | |
| Nanosphere Health has some characteristics of a very speculative penny stock | |
| Nanosphere Health appears to be risky and price may revert if volatility continues | |
| Nanosphere Health has high likelihood to experience some financial distress in the next 2 years | |
| Nanosphere Health Sciences has accumulated 44.7 K in total debt with debt to equity ratio (D/E) of 0.41, which is about average as compared to similar companies. Nanosphere Health has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nanosphere Health until it has trouble settling it off, either with new capital or with free cash flow. So, Nanosphere Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nanosphere Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nanosphere to invest in growth at high rates of return. When we think about Nanosphere Health's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (356.27 K) with profit before overhead, payroll, taxes, and interest of 218.03 K. | |
| Nanosphere Health Sciences has accumulated about 88.45 K in cash with (64.68 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 15.0% of Nanosphere Health outstanding shares are owned by corporate insiders |
- Analyzing Nanosphere Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nanosphere Health's stock is overvalued or undervalued compared to its peers.
- Examining Nanosphere Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nanosphere Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nanosphere Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nanosphere Health's pink sheet. These opinions can provide insight into Nanosphere Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nanosphere Pink Sheet analysis
When running Nanosphere Health's price analysis, check to measure Nanosphere Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanosphere Health is operating at the current time. Most of Nanosphere Health's value examination focuses on studying past and present price action to predict the probability of Nanosphere Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanosphere Health's price. Additionally, you may evaluate how the addition of Nanosphere Health to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |